Literature DB >> 26047965

Neuroleptic malignant syndrome and catatonia overlapping: 2 case reports.

Emanuel Loeb1, Jérémy Madigand, Joachim Alexandre, Sonia Dollfus, Antoine Coquerel, Sophie Fedrizzi.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26047965     DOI： 10.1007/s00213-015-3985-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  5 in total

1.  [A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses].

Authors:  J DELAY; P PICHOT; T LEMPERIERE; B ELISSALDE; F PEIGNE
Journal:  Ann Med Psychol (Paris)       Date:  1960-01       Impact factor: 0.380

Review 2.  Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma.

Authors:  Fabian U Lang; Silke Lang; Thomas Becker; Markus Jäger
Journal:  Psychopharmacology (Berl)       Date:  2014-11-20       Impact factor: 4.530

3.  The catatonic dilemma.

Authors:  I Brenner; W J Rheuban
Journal:  Am J Psychiatry       Date:  1978-10       Impact factor: 18.112

Review 4.  [Rating scales for assessing catatonia; which ones are the best?].

Authors:  J Rooseleer; A Willaert; P Sienaert
Journal:  Tijdschr Psychiatr       Date:  2011

5.  Catatonia. I. Rating scale and standardized examination.

Authors:  G Bush; M Fink; G Petrides; F Dowling; A Francis
Journal:  Acta Psychiatr Scand       Date:  1996-02       Impact factor: 6.392
  5 in total
  2 in total

1.  Still trying to solve the catatonic dilemma--A comment on the Letter to the Editor by Loeb et al. (Psychopharmacology, 2015).

Authors:  Fabian U Lang; Silke Lang; Thomas Becker; Markus Jäger
Journal:  Psychopharmacology (Berl)       Date:  2015-06-09       Impact factor: 4.530

2.  Catatonia in older adults: A systematic review.

Authors:  Walter Jaimes-Albornoz; Angel Ruiz de Pellon-Santamaria; Ayar Nizama-Vía; Marco Isetta; Ines Albajar; Jordi Serra-Mestres
Journal:  World J Psychiatry       Date:  2022-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.